Financial News
Bioventus Inc. - Class A Common Stock (NQ:BVS)
7.820
+0.040
(+0.51%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Apr 17, 2025
Add to My Watchlist
Price and Volume
Detailed Quote| Volume | 323,594 |
| Open | 7.740 |
| Bid (Size) | 7.810 (5) |
| Ask (Size) | 7.820 (77) |
| Prev. Close | 7.780 |
| Today's Range | 7.585 - 7.882 |
| 52wk Range | 3.900 - 14.38 |
| Shares Outstanding | N/A |
| Dividend Yield | N/A |
Top News
More News
Performance
More News
Read More
Earnings Scheduled For March 11, 2025
March 11, 2025
Dow Jumps 400 Points; Yum! Brands Posts Downbeat Earnings
November 05, 2024
S&P 500 Gains 1%; Vimeo Shares Spike Higher
November 05, 2024
12 Health Care Stocks Moving In Tuesday's Intraday Session
November 05, 2024
Nasdaq Gains Over 100 Points; US Trade Deficit Widens In September
November 05, 2024
Bioventus Reports Third Quarter Financial Results
November 05, 2024
Solventum Stock Earns 81 RS Rating
October 15, 2024
Executives Buying W. P. Carey And 2 Other Stocks
August 21, 2024
Bioventus Reports Second Quarter Financial Results
August 06, 2024
Frequently Asked Questions
Is Bioventus Inc. - Class A Common Stock publicly traded?
Yes, Bioventus Inc. - Class A Common Stock is publicly traded.
What exchange does Bioventus Inc. - Class A Common Stock trade on?
Bioventus Inc. - Class A Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Bioventus Inc. - Class A Common Stock?
The ticker symbol for Bioventus Inc. - Class A Common Stock is BVS on the Nasdaq Stock Market
What is the current price of Bioventus Inc. - Class A Common Stock?
The current price of Bioventus Inc. - Class A Common Stock is 7.820
When was Bioventus Inc. - Class A Common Stock last traded?
The last trade of Bioventus Inc. - Class A Common Stock was at 04/17/25 04:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
